Quantinno Capital Management LP Grows Stock Holdings in Envista Holdings Co. (NYSE:NVST)

Quantinno Capital Management LP raised its stake in shares of Envista Holdings Co. (NYSE:NVST - Free Report) by 54.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 86,056 shares of the company's stock after buying an additional 30,264 shares during the period. Quantinno Capital Management LP owned about 0.05% of Envista worth $1,660,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the stock. Venturi Wealth Management LLC grew its holdings in Envista by 528.4% during the fourth quarter. Venturi Wealth Management LLC now owns 1,948 shares of the company's stock worth $38,000 after acquiring an additional 1,638 shares during the period. Mitsubishi UFJ Trust & Banking Corp purchased a new stake in Envista in the 4th quarter worth approximately $86,000. KBC Group NV grew its stake in shares of Envista by 63.9% during the 4th quarter. KBC Group NV now owns 7,903 shares of the company's stock worth $152,000 after purchasing an additional 3,082 shares during the period. Tower Research Capital LLC TRC increased its holdings in shares of Envista by 51.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 11,057 shares of the company's stock valued at $213,000 after purchasing an additional 3,751 shares in the last quarter. Finally, Sterling Capital Management LLC lifted its stake in shares of Envista by 53.9% in the 4th quarter. Sterling Capital Management LLC now owns 11,105 shares of the company's stock valued at $214,000 after purchasing an additional 3,888 shares during the period.

Envista Price Performance

Shares of NYSE:NVST traded up $1.01 during trading on Tuesday, reaching $17.73. The stock had a trading volume of 590,662 shares, compared to its average volume of 2,555,878. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.76 and a current ratio of 2.04. Envista Holdings Co. has a 1-year low of $14.22 and a 1-year high of $23.00. The stock has a market cap of $3.00 billion, a PE ratio of -2.73, a PEG ratio of 1.27 and a beta of 0.97. The business has a fifty day moving average price of $16.56 and a 200-day moving average price of $18.79.

Envista (NYSE:NVST - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported $0.24 earnings per share for the quarter, beating analysts' consensus estimates of $0.20 by $0.04. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. The company had revenue of $616.90 million for the quarter, compared to analyst estimates of $608.17 million. During the same quarter last year, the firm posted $0.26 EPS. The firm's revenue for the quarter was down 1.1% on a year-over-year basis. On average, equities analysts forecast that Envista Holdings Co. will post 1 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts recently commented on NVST shares. New Street Research set a $19.00 price target on shares of Envista in a research report on Thursday, March 6th. Morgan Stanley set a $16.00 target price on Envista in a research report on Tuesday, April 15th. Robert W. Baird upgraded Envista from a "neutral" rating to an "outperform" rating and set a $23.00 price target for the company in a research note on Tuesday. Needham & Company LLC reiterated a "hold" rating on shares of Envista in a research report on Thursday, March 6th. Finally, JPMorgan Chase & Co. dropped their price objective on Envista from $20.00 to $19.00 and set a "neutral" rating on the stock in a report on Thursday, March 6th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $20.23.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.